Breaking

Anthropic Fights Trump Administration Over AI Model Export Controls Lex Marie's Art Confronts Discipline in Black Households Concerns Mount Over DHS Role in Election Security Amidst Election Denial Claims Tiny Transparent Fish and AI: Janelia's High-Stakes Bet on Brain Science Commodore Revives Flip Phone Era with Callback 8020 Respond.io raises $62.5M Series B to scale customer conversation management platform Vozinha, 40, Shines in World Cup Debut with Stellar Goalkeeping Performance Oklahoma Primaries Test Trump's Influence in Key Races Edwards Air Force Base: A History of Innovation and Tragedy Iranian Americans Protest, Divide Over Team at World Cup Match Anthropic Fights Trump Administration Over AI Model Export Controls Lex Marie's Art Confronts Discipline in Black Households Concerns Mount Over DHS Role in Election Security Amidst Election Denial Claims Tiny Transparent Fish and AI: Janelia's High-Stakes Bet on Brain Science Commodore Revives Flip Phone Era with Callback 8020 Respond.io raises $62.5M Series B to scale customer conversation management platform Vozinha, 40, Shines in World Cup Debut with Stellar Goalkeeping Performance Oklahoma Primaries Test Trump's Influence in Key Races Edwards Air Force Base: A History of Innovation and Tragedy Iranian Americans Protest, Divide Over Team at World Cup Match

CAR-T Cell

Steady3 stories2 sourcesLast updated: 5d ago

Related Topicscâncer terapia celular linfoma não-Hodgkin leucemia linfoide aguda USP Hemocentro de Ribeirão Preto Instituto Butantan Anvisa

Latest Stories

Publicitário de 64 anos tem remissão total de linfoma após terapia CAR-T Cell da USP

Health·5d agoAI summary

Publicitário de 64 anos tem remissão total de linfoma após terapia CAR-T Cell da USP

Paulo Peregrino, 64, alcançou remissão total de linfoma não-Hodgkin após tratamento com terapia CAR-T Cell desenvolvida no Brasil. A técnica reprograma células de defesa para combater o câncer, oferecendo esperança para casos agressivos.

Lucas Visconti, médico que lutou contra leucemia, morre aos 30 anos

5/22/2026AI summary

Lucas Visconti, médico que lutou contra leucemia, morre aos 30 anos

Lucas Visconti, médico e ex-aluno da UNIFAA, faleceu após uma longa batalha contra a leucemia, diagnosticada em 2017. Ele enfrentou remissões, recaídas e tratamentos inovadores como CAR-T Cell, sonhando em se especializar para ajudar outros pacientes.

CAR-T Cell Therapy Shows Promise for HIV Control in Early Trials

Health·5/18/2026AI summary

CAR-T Cell Therapy Shows Promise for HIV Control in Early Trials

CAR-T cell therapy, a cancer treatment, is being repurposed for HIV. Early results show two individuals achieving undetectable viral loads and stopping HIV medication after a single infusion of engineered immune cells.